Patient and Caregiver Attitudes toward Disorders of Sex Development Nomenclature.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 18 4 2020
medline: 30 10 2020
entrez: 18 4 2020
Statut: ppublish

Résumé

The medical terminology applied to differences/disorders of sex development has been viewed negatively by some affected individuals. A clinical population of patients with differences/disorders of sex development and their caregivers were surveyed regarding current nomenclature, hypothesizing that those unaffiliated with support groups would have more favorable attitudes. We recruited English and Spanish speaking patients 13 years old or older with differences/disorders of sex development and their caregivers at 5 national tertiary care clinics from July 2016 to December 2018. No diagnoses were excluded. Participants completed a survey rating terminology commonly applied to differences/disorders of sex development. Responses were compared between subgroups, including members vs nonmembers of a support group. Of 185 potential participants approached 133 completed the survey (72% response rate). Congenital adrenal hyperplasia (33%) was the most common diagnosis. "Variation of sex development" was the most liked term (37%) but was not liked more significantly than "disorders of sex development" (27%, p=0.16). No term was liked by a majority of respondents. "Disorders of sex development" (37%) and "intersex" (53%) were the only terms most frequently viewed unfavorably. Support group members were significantly more likely to dislike the term "intersex" (p=0.02) and to like "variation of sex development" (p=0.02). A clinical population of patients and their caregivers had generally neutral attitudes toward nomenclature applied to differences/disorders of sex development. Members of a support group had clearer terminology preferences. "Variation of sex development" was the most liked term, and "disorders of sex development" and "intersex" were the most disliked. No term was liked by most respondents, and no clear alternative to the present nomenclature was identified.

Identifiants

pubmed: 32302259
doi: 10.1097/JU.0000000000001076
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

835-842

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Anthony D'Oro (A)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Ilina Rosoklija (I)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Deborah L Jacobson (DL)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Courtney Finlayson (C)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Diane Chen (D)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Duong D Tu (DD)

Texas Children's Hospital, Houston, Texas.

Paul F Austin (PF)

Texas Children's Hospital, Houston, Texas.

Lefkothea P Karaviti (LP)

Texas Children's Hospital, Houston, Texas.

Sheila K Gunn (SK)

Texas Children's Hospital, Houston, Texas.

Leena Nahata (L)

Nationwide Children's Hospital, Columbus, Ohio.

Hillary M Kapa (HM)

Nationwide Children's Hospital, Columbus, Ohio.

Paul J Kokorowski (PJ)

Children's Hospital Los Angeles, Los Angeles, California.

Mimi S Kim (MS)

Children's Hospital Los Angeles, Los Angeles, California.

Alyssa C Messina (AC)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Thomas F Kolon (TF)

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Elizabeth B Yerkes (EB)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Earl Y Cheng (EY)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Emilie K Johnson (EK)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH